Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-07-26

Clinical Trial Update: Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes [NA]

View source ↗

Summary

Clinical trial update on the safety and effectiveness of duodenal mucosal resurfacing (DMR) with the Revita system for type 2 diabetes; study completed with pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Revita System

Snippet

Sponsor: Fractyl Health Inc. | Conditions: Type 2 Diabetes | NA | Status: COMPLETED | Results posted: 2022-07-26